Company intelligence

IVA

Inventiva S.A. · NASDAQ · Healthcare

Price$3.56+2.89% · +$0.10

Market cap185.06MEquity value

P / E-1.2Trailing ratio

Volume4.89MLatest session

Market data

IVA price chart

TradingView

Related signals

1 min delayed

Browse public IVA signals with their source context and measured market impact. Open any signal for its permanent analysis page.

IVAJan 28, 2026-7.75% since signal

Biotech Inventiva's 50% surge shows investor optimism over liver disease drug

Inventiva's stock has experienced a remarkable 50% rise in early 2026, driven by optimism surrounding its upcoming entry into the liver disease treatment market. This interest underscores growing investor confidence in the biotech's potential despite its current losses.

View signal analysis

IVASep 29, 2025-3.97% since signal

Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Inventiva reported a loss of $1.84 per share, exceeding estimates by $1.43. Quarterly sales of $5.050 million missed the consensus estimate of $5.310 million. Shares fell 5.5% to $5.72 in pre-market trading due to disappointing results. Broader market trends show positive futures, but IVA is down today. Other biotech stocks are also experiencing significant declines in pre-market trading.

View signal analysis

Research